Skip to main content
. Author manuscript; available in PMC: 2018 Dec 20.
Published in final edited form as: Toxicol Appl Pharmacol. 2011 Feb 19;252(3):237–249. doi: 10.1016/j.taap.2011.02.012

Fig. 1.

Fig. 1.

Systemic effects of low-dose clofibrate pretreatment in FFAs-binding BSA-injected mice. (A) Daily urine volume and daily urinary protein excretion. (B and C) Serum concentrations of total protein and urea nitrogen, respectively. The clofibrate-pretreatment group was fed a 0.1% clofibrate-containing diet from two weeks before daily FFAs-binding BSA injection. The start time point of FFAs-binding BSA injection was designated as day 0. Values represent means±SD (n = 3, 5, and 6 for each group at day 0, 10, and 17, respectively).